Erik Ostrowski Akebia Therapeutics, Inc. (AKBA) insider trading activity

AKBA Quotes by TradingView

Erik Ostrowski is SVP, CFO, CBO & Treasurer of Akebia Therapeutics, Inc.. Currently has a direct ownership of 503,586 shares of AKBA, which is worth approximately $1.82 Million. The most recent transaction as insider was on Jun 30, 2025, when has been sold 41,314 shares (Common Stock) at a price of $3.67 per share, resulting in proceeds of $151,622. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 504K
7.58% 3M change
43.88% 12M change
Total Value Held $1.82 Million

Erik Ostrowski Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 30 2025
SELL
Open market or private sale
$151,622 $3.67 p/Share
41,314 Reduced 7.58%
503,586 Common Stock
Jan 31 2025
BUY
Grant, award, or other acquisition
-
194,900 Added 26.34%
544,900 Common Stock
Jun 28 2024
BUY
Grant, award, or other acquisition
-
350,000 Added 50.0%
350,000 Common Stock

Also insider at

AVRO
AVROBIO, Inc. Healthcare
Interim CEO, President and CFO
EO

Erik Ostrowski

SVP, CFO, CBO & Treasurer
Cambridge, MA

Track Institutional and Insider Activities on AKBA

Follow Akebia Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AKBA shares.

Notify only if

Insider Trading

Get notified when an Akebia Therapeutics, Inc. insider buys or sells AKBA shares.

Notify only if

News

Receive news related to Akebia Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AKBA